Game-changing value proposition for early diagnosis and effective intervention of sarcopenia syndrome: the progressive loss of skeletal muscle that comes with aging

Sarcopenia is a disease that causes progressive weakness with loss of muscle mass and quality and mainly affects people over 60 years of age. The iSarc-Genetics project, led by Dawako and Sabartech, was born with the aim of becoming the first platform for precision medicine and digital health for the early detection of sarcopenia, helping to diagnose and monitor this disease

The companies of the Science Park of the University of Valencia are supported by the Valencian Innovation Agency (AVI) to carry out the iSarc-Genetics project (INNEST/2021/348) in collaboration with research groups of the University of Valencia (CoMMlab) and the Polytechnic University of Valencia (Ci2B)

PIIXMED™ iSarc™ will be the unique non-invasive, patient convenient and cost-effective clinical solution for diagnosis and intervention of sarcopenia, based on AI-powered quantitative ultrasound imaging biomarkers cloud-based system